盐酸倍他洛尔代谢产物的β-肾上腺素能阻滞及抗心律失常活性（作者译） - Suppr | 超能文献

[The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].

作者信息

Masumoto S, Inoue H, Maruyama Y

出版信息

Nihon Yakurigaku Zasshi. 1979 Jul;75(5):517-25. doi: 10.1254/fpj.75.517.

DOI:10.1254/fpj.75.517

PMID:44259

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].盐酸倍他洛尔代谢产物的β-肾上腺素能阻滞及抗心律失常活性（作者译）

Nihon Yakurigaku Zasshi. 1979 Jul;75(5):517-25. doi: 10.1254/fpj.75.517.

2

[Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].新型β-肾上腺素能阻滞剂盐酸dl-2-（3'-叔丁氨基-2'-羟丙基硫代）-4-（5'-氨基甲酰基-2'-噻吩基）噻唑（S-596）的药理特性（作者译）

Nihon Yakurigaku Zasshi. 1979 Oct;75(7):707-20.

3

Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.β-肾上腺素受体研究。4. 白蛋白对普萘洛尔、吲哚洛尔、普拉洛尔和美托洛尔的体外β-肾上腺素受体阻断及抗心律失常特性的影响。

Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):29-36. doi: 10.1007/BF00510983.

4

Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.β-肾上腺素能阻滞剂5-甲基-8-(2-羟基-3-叔丁氨基丙氧基)香豆素盐酸盐（布库洛尔）的右旋和左旋异构体对乌头碱诱发的犬心房心律失常及哇巴因诱发的犬心室心律失常的抗心律失常活性。

Jpn J Pharmacol. 1979 Dec;29(6):935-45. doi: 10.1254/jjp.29.935.

5

Antiarrhythmic action of a new beta-adrenergic blocking agent, 6-(2-hydroxy-3-isopropylaminopropyloxy)-benzothiazole succinate (KF-577), compared with that of propranolol.新型β-肾上腺素能阻滞剂6-(2-羟基-3-异丙氨基丙氧基)-苯并噻唑琥珀酸盐（KF-577）与普萘洛尔抗心律失常作用的比较。

Eur J Pharmacol. 1976 Nov;40(1):145-52. doi: 10.1016/0014-2999(76)90364-2.

6

[Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].[心血管药物研究。VII. 盐酸1-叔丁氨基-3-(邻-(四氢呋喃氧基)-苯氧基)-2-丙醇(Y-6124)的肾上腺素能受体阻断活性]

Yakugaku Zasshi. 1972 Apr;92(4):375-83. doi: 10.1248/yakushi1947.92.4_375.

7

Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.新型β受体阻滞剂1-（邻甲氧基苯氧基）-3-异丙氨基-2-丙醇盐酸盐（S-D-1601）的药理作用

Arzneimittelforschung. 1970 Aug;20(8):1074-9.

8

A potent new beta2-adrenoceptor blocking agent.一种强效的新型β2肾上腺素能受体阻断剂。

Br J Pharmacol. 1977 Jul;60(3):357-62. doi: 10.1111/j.1476-5381.1977.tb07508.x.

9

[Drug effects on blood pressure and heart rate in unanesthetized animals. (1). Effects of beta-blocking agents (author's transl)].[药物对未麻醉动物血压和心率的影响。(1). β受体阻滞剂的作用（作者译）]

Nihon Yakurigaku Zasshi. 1977 May;73(4):401-9. doi: 10.1254/fpj.73.401.

10

Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.心脏选择性β肾上腺素能拮抗剂CI-775的药理学评价

Arch Int Pharmacodyn Ther. 1977 Mar;226(1):81-99.

引用本文的文献

1

Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.新型β-肾上腺素受体阻断药倍他洛尔的临床药理学。与普萘洛尔重复给药的交叉比较。

Eur J Clin Pharmacol. 1982;23(3):189-95. doi: 10.1007/BF00547552.